Permira launches €3bn-€4bn Neuraxpharm sale as lenders prep €1.5bn debt financing
Private equity firm Permira has officially launched the sale of German pharmaceutical company Neuraxpharm, with lenders preparing financing packages of up to €1.5bn ($1.8bn) for prospective buyers, according to a report by Bloomberg.